These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 9133974

  • 1. Sulphasalazine in the treatment of rheumatoid arthritis.
    Box SA, Pullar T.
    Br J Rheumatol; 1997 Mar; 36(3):382-6. PubMed ID: 9133974
    [No Abstract] [Full Text] [Related]

  • 2. Which component of sulphasalazine is active in rheumatoid arthritis?
    Pullar T, Hunter JA, Capell HA.
    Br Med J (Clin Res Ed); 1985 May 25; 290(6481):1535-8. PubMed ID: 2860942
    [Abstract] [Full Text] [Related]

  • 3. Which component of sulphasalazine is active in rheumatoid arthritis?
    Situnayake RD, McConkey B.
    Br Med J (Clin Res Ed); 1985 Jul 13; 291(6488):138. PubMed ID: 2861878
    [No Abstract] [Full Text] [Related]

  • 4. 5-Aminosalicylic acid or sulphapyridine. Which is the active moiety of sulphasalazine in rheumatoid arthritis?
    Taggart AJ, Neumann VC, Hill J, Astbury C, Le Gallez P, Dixon JS.
    Drugs; 1986 Jul 13; 32 Suppl 1():27-34. PubMed ID: 2877851
    [Abstract] [Full Text] [Related]

  • 5. Is there a role for antibiotics in the treatment of patients with rheumatoid arthritis?
    O'Dell JR.
    Drugs; 1999 Mar 13; 57(3):279-82. PubMed ID: 10193682
    [Abstract] [Full Text] [Related]

  • 6. Sulphasalazine in rheumatoid arthritis: pointers to a gut-mediated immune effect.
    Sheldon PJ, Webb C, Grindulis KA.
    Br J Rheumatol; 1987 Aug 13; 26(4):318-9. PubMed ID: 2886178
    [No Abstract] [Full Text] [Related]

  • 7. [Thrombocytopenia in a patient with rheumatoid arthritis during sulphasalazine therapy].
    Keso L, Kaarela K, Oksanen K, Ahonen M.
    Duodecim; 1998 Aug 13; 114(17):1731-3. PubMed ID: 11717780
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Radical Intervention in Early Rheumatoid Arthritis. The Case for Enteric-Coated Sulphasalazine, Methotrexate and Combination Regimes. Proceedings of a workshop. Camogli, Italy, September 1994.
    Br J Rheumatol; 1995 Nov 13; 34 Suppl 2():1-112. PubMed ID: 8535638
    [No Abstract] [Full Text] [Related]

  • 11. Changing sulphasalazine to methotrexate does not improve the 2-year outcomes of the initial single DMARD treatment in early rheumatoid arthritis: subanalysis of the FIN-RACo trial.
    Rantalaiho VM, Kautiainen H, Korpela M, Hannonen PJ, Leirisalo-Repo M, Möttönen T, FIN-RACo Trial Group.
    Ann Rheum Dis; 2013 May 13; 72(5):786-8. PubMed ID: 23349132
    [No Abstract] [Full Text] [Related]

  • 12. A study to determine the active moiety of sulphasalazine in rheumatoid arthritis.
    Neumann VC, Taggart AJ, Le Gallez P, Astbury C, Hill J, Bird HA.
    J Rheumatol; 1986 Apr 13; 13(2):285-7. PubMed ID: 2873245
    [Abstract] [Full Text] [Related]

  • 13. Cyclosporin for sulphasalazine-induced aplastic anaemia in a patient with early rheumatoid arthritis.
    Nurmohamed MT, Soesan M, van Oers MH, Dijkmans BA, van Soesbergen RM.
    Rheumatology (Oxford); 2000 Dec 13; 39(12):1431-3. PubMed ID: 11136894
    [No Abstract] [Full Text] [Related]

  • 14. Combination of sulphasalazine and methotrexate in the management of rheumatoid arthritis--view based on personal clinical experience.
    Shiroky JB.
    Br J Rheumatol; 1995 Nov 13; 34 Suppl 2():109-12. PubMed ID: 8535641
    [Abstract] [Full Text] [Related]

  • 15. [Association between AIF-1 gene polymorphisms and response to rheumatoid arthritis treatment with sulphasalazine].
    Dabrowska-Zamojcin E, Herczyńska MM, Pawlik A.
    Ann Acad Med Stetin; 2013 Nov 13; 59(2):39-42. PubMed ID: 25026748
    [Abstract] [Full Text] [Related]

  • 16. Sulphasalazine-induced autoimmune abnormalities in patients with rheumatic disease.
    Borg AA.
    Br J Rheumatol; 1995 Nov 13; 34(11):1097-8. PubMed ID: 8542218
    [No Abstract] [Full Text] [Related]

  • 17. The effect of sulphasalazine on neutrophil superoxide generation in rheumatoid arthritis.
    Bradley SM, le Gallez P, Throughton PR, Gooi HC, Astbury C, Bird HA.
    Br J Rheumatol; 1997 May 13; 36(5):530-4. PubMed ID: 9189053
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study Group.
    Smolen JS, Kalden JR, Scott DL, Rozman B, Kvien TK, Larsen A, Loew-Friedrich I, Oed C, Rosenburg R.
    Lancet; 1999 Jan 23; 353(9149):259-66. PubMed ID: 9929017
    [Abstract] [Full Text] [Related]

  • 19. Clinical efficacy of sulphasalazine--a review.
    Capell HA.
    Br J Rheumatol; 1995 Nov 23; 34 Suppl 2():35-9. PubMed ID: 8535647
    [Abstract] [Full Text] [Related]

  • 20. Combining sulphasalazine and methotrexate in rheumatoid arthritis: early clinical impressions.
    Haagsma CJ, van Riel PL, van de Putte LB.
    Br J Rheumatol; 1995 Nov 23; 34 Suppl 2():104-8. PubMed ID: 8535640
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.